Author:
Raksasat Raksit,Teerapittayanon Surat,Itthipuripat Sirawaj,Praditpornsilpa Kearkiat,Petchlorlian Aisawan,Chotibut Thiparat,Chunharas Chaipat,Chatnuntawech Itthi
Abstract
AbstractDementia is a debilitating neurological condition which impairs the cognitive function and the ability to take care of oneself. The Clock Drawing Test (CDT) is widely used to detect dementia, but differentiating normal from borderline cases requires years of clinical experience. Misclassifying mild abnormal as normal will delay the chance to investigate for potential reversible causes or slow down the progression. To help address this issue, we propose an automatic CDT scoring system that adopts Attentive Pairwise Interaction Network (API-Net), a fine-grained deep learning model that is designed to distinguish visually similar images. Inspired by how humans often learn to recognize different objects by looking at two images side-by-side, API-Net is optimized using image pairs in a contrastive manner, as opposed to standard supervised learning, which optimizes a model using individual images. In this study, we extend API-Net to infer Shulman CDT scores from a dataset of 3108 subjects. We compare the performance of API-Net to that of convolutional neural networks: VGG16, ResNet-152, and DenseNet-121. The best API-Net achieves an F1-score of 0.79, which is a 3% absolute improvement over ResNet-152’s F1-score of 0.76. The code for API-Net and the dataset used have been made available at https://github.com/cccnlab/CDT-API-Network.
Funder
National Research Council of Thailand
Foundation of Thai Gerontology Research and Development Institute
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Kisa, A. et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the global burden of disease study 2019. Lancet Public Health 21, e105–e125 (2022).
2. Vickrey, B. et al. The effect of a disease management intervention on quality and outcomes of dementia care: A randomized, controlled trial. Ann. Intern. Med. 145, 713–26. https://doi.org/10.7326/0003-4819-145-10-200611210-00004 (2006).
3. Voisin, T. & Vellas, B. Diagnosis and treatment of patients with severe Alzheimer’s disease. Drugs Aging 26, 135–144 (2009).
4. Folstein, M. F., Folstein, S. E. & McHugh, P. R. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189–198 (1975).
5. Nasreddine, Z. S. et al. The montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53, 695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x (2005).